NEFA (Non Esterified Fatty Acid) , Adipose Factors Behind Insulin Sensitivity
NCT ID: NCT01727245
Last Updated: 2020-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
500 participants
INTERVENTIONAL
2011-11-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adipose Inflammation and Diabetes (FAB)
NCT04255264
Mechanisms Underlying Postoperative Insulin Resistance and Inflammation
NCT01470534
Fat Cell Size in Insulin Resistance
NCT00341406
Impaired Adipogenesis in Insulin Resistance: Pilot Clinical and In Vitro Studies
NCT00560469
Iron and Insulin Resistance in Overweight and Obese Humans
NCT03348020
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese
Obese patients undergoing gastric by-pass surgery
Obese
gastric bypass
Control group
Cholecystectomy and anti-reflux surgery
Control group
Cholecystectomy and anti-reflux surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Obese
gastric bypass
Control group
Cholecystectomy and anti-reflux surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI under 30
Exclusion Criteria
* oral or parenteral steroid treatment
* complicated psychiatric disease
* Warfarin use
* diabetes
* oral or parenteral steroids treatment
* complicated psychiatric disease
* Warfarins use
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danderyd Hospital
OTHER
Ersta Hospital, Sweden
OTHER
Karolinska University Hospital
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erik Näslund
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erik Näslund, Prof.
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ersta Hospital
Stockholm, , Sweden
Karolinska University Hospital
Stockholm, , Sweden
Danderyds Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mileti E, Kwok KHM, Andersson DP, Mathelier A, Raman A, Backdahl J, Jalkanen J, Massier L, Thorell A, Gao H, Arner P, Mejhert N, Daub CO, Ryden M. Human White Adipose Tissue Displays Selective Insulin Resistance in the Obese State. Diabetes. 2021 Jul;70(7):1486-1497. doi: 10.2337/db21-0001. Epub 2021 Apr 16.
Backdahl J, Andersson DP, Eriksson-Hogling D, Caidahl K, Thorell A, Mileti E, Daub CO, Arner P, Ryden M. Long-Term Improvement in Aortic Pulse Wave Velocity After Weight Loss Can Be Predicted by White Adipose Tissue Factors. Am J Hypertens. 2018 Mar 10;31(4):450-457. doi: 10.1093/ajh/hpx201.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/1002-31/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.